Celldex Therapeutics, Inc. (CLDX) NASDAQ

26.83

+0.25(+0.94%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap1.63B
Enterprise Value1.6B
P/E Ratio-7.94
PEG Ratio0.65
Price/Sales Ratio685.7
Price/Book Ratio2.98
Enterprise/Revenue672.85
Enterprise/EBITDA-6.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-86.36
Operating Margin-98.55

Management Effectiveness

Return On Assets-0.35
Return On Equity-0.33

Income Statement

Revenue7.02M
Revenue/Share0.04
Gross Profit-156.53M
EBITDA-191.9M
Net Income-157.86M
Diluted EPS-2.45

Balance Sheet

Total Cash583.22M
Total Cash/Share8.78
Total Debt2.62M
Total Debt/Equity0
Current Ratio13.01
Book Value Per Share9.01

Price History

52-Week Change4.6
52-Week High30.5
52-Week Low14.4
Moving Average 50 Days26.29
Moving Average 200 Days22.75

Statistics

Average Volume844,174
Shares Outstanding66.45M
% Held by Institutions106.53

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateFebruary 11, 2019